ArticleBlood neoplasia2026
Real-world clinical outcomes in patients with CLL previously treated with covalent BTKi and BCL2i regimens.
Jennifer Prescott et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it